Q4 2016 Holdings
Filed 2017-02-14 | 77 holdings | $88.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $10.1K | 1,150,000 | 0.0% |
| Inc Resh Hldgs Inc | CL A | 45329R109 | $10.5K | 200,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $12.1K | 537,000 | 0.0% |
| China Biologic Prods Inc | COM | 16938C106 | $12.1K | 112,867 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $13.3K | 507,907 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $13.9K | 359,000 | 0.0% |
| Quotient LTD | SHS | G73268107 | $14.2K | 2,940,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $15.8K | 720,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $18.7K | 1,445,090 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $20.9K | 2,333,333 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $21.1K | 2,500,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $21.4K | 334,044 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $23.6K | 841,752 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $25.6K | 1,951,263 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $31.2K | 2,652,436 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $32.5K | 410,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $32.9K | 1,581,604 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $43.7K | 601,044 | 0.0% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $45.4K | 1,425,000 | 0.1% |
| Proteostasis Therapeutics in | COM | 74373B109 | $46.6K | 3,804,027 | 0.1% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.8M | 198,526 | 3.2% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $3.3M | 162,254 | 3.7% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.1M | 371,636 | 4.6% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $7.1M | 455,515 | 8.0% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $14.6M | 519,090 | 16.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $26.5M | 976,286 | 29.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $29.4M | 2,071,964 | 33.3% |